MUC16 and ovarian carcinoma: The ovarian cancer biomarker MUC16 (also known as CA125) was mutated even more frequently in EC (20%) and CC (29%) samples (compared to 12% in OC), suggesting a common role of MUC16 among gynecologic cancers.